Who owns CSTL?
Institutional ownership of Castle Biosciences Inc. from Form 13F, Q2 2026
176 institutional managers reported holding Castle Biosciences Inc. (CSTL) in Form 13F filings for Q2 2026, with 27,341,828 shares worth $653M. The largest reported holder was BlackRock, Inc. Managers that filed both quarters cut a net 266,650 shares (-1.0%). 21 opened new positions and 30 sold out.
- Funds holding
- 176
- Value held
- $653M
- New / sold out
- 21 / 30
- Net shares, same filers
- -1.0%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of CSTL
Share of 13F holdings is each fund's shares as a share of the 27,341,828 CSTL shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- Mackenzie Financial Corp Added+$17.2M
- Jefferies Financial Group Inc. New+$15.4M
- Acadian Asset Management LLC Added+$10.4M
- Point72 Asset Management, L.P. New+$8.5M
- Kennedy Capital Management LLC New+$8.3M
- BlackRock, Inc. Added+$7.4M
- First Trust Advisors LP New+$3.5M
- Citadel Advisors LLC Added+$3.4M
- Allspring Global Investments Holdings, LLC Added+$3.1M
- AQR Capital Management LLC Added+$2.4M
Biggest sellers in Q2 2026
- Portolan Capital Management, LLC Trimmed-$24.4M
- Eventide Asset Management, LLC Sold out-$9.5M
- Palisade Capital Management, LP Trimmed-$7.2M
- Schroder Investment Management Group Sold out-$7.0M
- Nuveen, LLC Trimmed-$6.9M
- SG Americas Securities, LLC Sold out-$6.0M
- Dimensional Fund Advisors LP Trimmed-$5.9M
- Tudor Investment Corp Et Al Trimmed-$5.0M
- Wasatch Advisors LP Trimmed-$4.2M
- Renaissance Technologies LLC Trimmed-$3.9M
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $108M and sold $115M; 77 added and 54 trimmed.
Schedule 13D and 13G filings on CSTL
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2025-10-09DIMENSIONAL FUND ADVISORS LP SCHEDULE 13G filed by Castle Biosciences Inc.Schedule 13G
- 2025-04-14Portolan Capital Management, LLC SCHEDULE 13G filed by Castle Biosciences Inc.Schedule 13G
Questions about CSTL ownership
- Who owns CSTL stock?
- 176 institutional investment managers reported CSTL positions in their Form 13F filings for Q2 2026, holding 27,341,828 shares worth $653M in total. BlackRock, Inc. reported the largest position.
- Are funds buying or selling CSTL?
- In Q2 2026, 21 managers opened new CSTL positions, 77 added, 54 trimmed and 30 sold out. Managers that filed in both quarters sold a net 266,650 shares.
- How current is this CSTL institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to CSTL by CUSIP. Options are left out. CSTL news and filings · CSTL insider trades · Top funds